Shares of Avidity Biosciences RNA rose more than 12% on Wednesday after the company announced that it is expanding its current RNA-based pipeline of rare muscle disorders to explore a new therapeutic ...

To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...

The "North America RNA Therapeutics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been ...

The researchers found cordycepin triphosphate blocks two separate signaling pathways often hijacked by cancer cells to assist ...

Zymo’s Quick DNA/RNA Viral MagBead Kit was automated using Analytik Jena’s Cybio FeliX pipetting robot. The CyBio FeliX ...

Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset——Joint poster with Bachem demonstrates ...

Novavax incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 per ...

Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled. A ...

Researchers from VIB and VUB now provide an interactive tool, based on a single-cell RNA-sequencing (scRNA-seq) atlas of the ...

Cancer has a high death rate with delayed diagnosis of the disease being one of the main reasons for its fatality. Early ...

A new study presents "Evo" – a machine learning model capable of decoding and designing DNA, RNA, and protein sequences, from ...

At TED AI 2024 in October, one of those eight researchers, Jakob Uszkoreit, spoke with Ars Technica about the development of ...